Internal Medicine Journal

Papers
(The H4-Index of Internal Medicine Journal is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management117
How COVID‐19 has pushed us into a medical education revolution75
Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicentre retrospective study68
Telehealth in cancer care: during and beyond the COVID‐19 pandemic60
Consensus guidelines for the diagnosis and management of invasive aspergillosis, 202156
Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID‐19: a systematic review44
Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 202141
Health status and healthcare trends of individuals accessing Australian aged care programmes over a decade: the Registry of Senior Australians historical cohort41
Australian and New Zealand consensus statement on the management of lymphoma, chronic lymphocytic leukaemia and myeloma during the COVID‐19 pandemic35
Patient satisfaction and acceptability with telehealth at specialist medical outpatient clinics during the COVID‐19 pandemic in Australia35
Idiopathic inflammatory myopathies: a review32
Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry31
Nursing homes: the titanic of cruise ships – will residential aged care facilities survive the COVID‐19 pandemic?31
Effect of the COVID‐19 induced phase of massive telehealth uptake on end‐user satisfaction29
Immunosuppression as a risk factor for COVID‐19: a meta‐analysis28
2004 chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians: a comparative study28
Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology/oncology setting, 202127
Quality of care in inflammatory bowel disease: actual health service experiences fall short of the standards26
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant reci26
Machine learning in the prediction of medical inpatient length of stay26
Evaluation of the effect of COVID‐19 pandemic on anxiety severity of physicians working in the internal medicine department of a tertiary care hospital: a cross‐sectional survey24
Advance care planning in Australia during the COVID‐19 outbreak: now more important than ever23
Utilisation of telehealth for outpatient diabetes management during COVID‐19 pandemic: how did the patients fare?22
Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 202122
An overview of healthcare improvement: unpacking the complexity for clinicians and managers in a learning health system22
0.044318914413452